Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Not applicableStudy completedNCT00050921
What this trial is testing

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableStudy completedNCT00872872
What this trial is testing

Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)

Who this might be right for
NVP Plasma LevelNVP Related Mutation3TC Related Mutation
Thai Red Cross AIDS Research Centre 30
Post-approval studies (Phase 4)Study completedNCT00867048
What this trial is testing

Strategic Timing of Antiretroviral Treatment

Who this might be right for
HIV Infection
University of Minnesota 4,688
Testing effectiveness (Phase 2)Study completedNCT00807443
What this trial is testing

Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1

Who this might be right for
HIV-1HIV Infections
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)Study completedNCT01192035
What this trial is testing

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Who this might be right for
HIV-1
University of Aarhus 400
Testing effectiveness (Phase 2)Study completedNCT02054286
What this trial is testing

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

Who this might be right for
HIV Infection
Theravectys S.A. 38
Early research (Phase 1)UnknownNCT01428596
What this trial is testing

Safety and Immunogenicity of HIVAX in HIV-1 Infected Subjects

Who this might be right for
HIV Infections
GeneCure Biotechnologies 30
Not applicableStudy completedNCT00433030
What this trial is testing

Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 2,816
Testing effectiveness (Phase 2)Study completedNCT00833781
What this trial is testing

A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

Who this might be right for
HIV-1 InfectionHIV Infections
Massachusetts General Hospital 15
Not applicableStudy completedNCT00107679
What this trial is testing

Anal Cancer Development in HIV Infected People

Who this might be right for
HIV InfectionsAnus Neoplasms
National Institute of Allergy and Infectious Diseases (NIAID) 560
Not applicableEnded earlyNCT04138199
What this trial is testing

Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Who this might be right for
HIV-1 Infection
AbbVie 239